Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03658772
Title Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arrys Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Cancer Center - Scottsdale Phoenix Arizona 85054 United States Details
University of Colorado Denver-Anschutz Medical Campus Aurora Colorado 80045 United States Details
Sarah Cannon Research Institute, LLC (SCRI) Nashville Tennessee 37203 United States Details
New Experimental Therapeutics of San Antonio-NEXT Oncology San Antonio Texas 78240 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field